149 related articles for article (PubMed ID: 28180127)
1. Impact of Fecal Calprotectin Measurement on Decision-making in Children with Inflammatory Bowel Disease.
El-Matary W; Abej E; Deora V; Singh H; Bernstein CN
Front Pediatr; 2017; 5():7. PubMed ID: 28180127
[TBL] [Abstract][Full Text] [Related]
2. The Utility of Fecal Calprotectin in the Real-World Clinical Care of Patients with Inflammatory Bowel Disease.
Abej E; El-Matary W; Singh H; Bernstein CN
Can J Gastroenterol Hepatol; 2016; 2016():2483261. PubMed ID: 27774443
[No Abstract] [Full Text] [Related]
3. Faecal Calprotectin Is a Very Reliable Tool to Predict and Monitor the Risk of Relapse After Therapeutic De-escalation in Patients With Inflammatory Bowel Diseases.
Buisson A; Mak WY; Andersen MJ; Lei D; Kahn SA; Pekow J; Cohen RD; Zmeter N; Pereira B; Rubin DT
J Crohns Colitis; 2019 Aug; 13(8):1012-1024. PubMed ID: 30726887
[TBL] [Abstract][Full Text] [Related]
4. Faecal calprotectin is a surrogate marker of biliary inflammation in primary sclerosing cholangitis associated inflammatory bowel disease.
Pavlidis P; Joshi D; El Sherif Y; Warner B; Gulati S; Alexander J; Cross G; Dew T; Arqoub HA; Devlin J; Heneghan M; Dubois P; Bjarnason I; Powell N; Hayee B
Frontline Gastroenterol; 2022; 13(6):497-502. PubMed ID: 36250171
[TBL] [Abstract][Full Text] [Related]
5. Neopterin is a novel reliable fecal marker as accurate as calprotectin for predicting endoscopic disease activity in patients with inflammatory bowel diseases.
Nancey S; Boschetti G; Moussata D; Cotte E; Peyras J; Cuerq C; Haybrard J; Charlois AL; Mialon A; Chauvenet M; Stroeymeyt K; Kaiserlian D; Drai J; Flourié B
Inflamm Bowel Dis; 2013 Apr; 19(5):1043-52. PubMed ID: 23511035
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Accuracy of Fecal Calprotectin for Pediatric Inflammatory Bowel Disease in Primary Care: A Prospective Cohort Study.
Holtman GA; Lisman-van Leeuwen Y; Kollen BJ; Norbruis OF; Escher JC; Kindermann A; de Rijke YB; van Rheenen PF; Berger MY
Ann Fam Med; 2016 Sep; 14(5):437-45. PubMed ID: 27621160
[TBL] [Abstract][Full Text] [Related]
7. Fecal Eosinophil Cationic Protein Is a Diagnostic and Predictive Biomarker in Young Adults with Inflammatory Bowel Disease.
Abedin N; Seemann T; Kleinfeld S; Ruehrup J; Röseler S; Trautwein C; Streetz K; Sellge G
J Clin Med; 2019 Nov; 8(12):. PubMed ID: 31756948
[TBL] [Abstract][Full Text] [Related]
8. Development and investigation of a non-invasive disease severity index for inflammatory bowel disease.
Swaminathan A; Borichevsky GM; Frampton C; Kettle AJ; Peyrin-Biroulet L; Siegel CA; Day AS; Gearry RB
J Crohns Colitis; 2024 Jul; ():. PubMed ID: 38953471
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Fecal Calprotectin and Myeloperoxidase in Predicting Outcomes in Inflammatory Bowel Disease.
Swaminathan A; Borichevsky GM; Frampton CM; Day AS; Hampton MB; Kettle AJ; Gearry RB
Inflamm Bowel Dis; 2024 Feb; ():. PubMed ID: 38417068
[TBL] [Abstract][Full Text] [Related]
10. The novel latex agglutination turbidimetric immunoassay system for simultaneous measurements of calprotectin and hemoglobin in feces.
Hiraoka S; Takashima S; Inokuchi T; Nakarai A; Takahara M; Harada K; Seki Y; Watanabe K; Kato J; Okada H
Intest Res; 2019 Apr; 17(2):202-209. PubMed ID: 30541228
[TBL] [Abstract][Full Text] [Related]
11. Fecal immunochemical test as a biomarker for inflammatory bowel diseases: can it rival fecal calprotectin?
Kato J; Hiraoka S; Nakarai A; Takashima S; Inokuchi T; Ichinose M
Intest Res; 2016 Jan; 14(1):5-14. PubMed ID: 26884729
[TBL] [Abstract][Full Text] [Related]
12. Validation of the newly FDA-approved Buhlmann fCal Turbo assay for measurement of fecal calprotectin in a pediatric population.
Garnett E; Pagaduan J; Rajapakshe D; Tam E; Kellermayer R; Devaraj S
Pract Lab Med; 2020 Nov; 22():e00178. PubMed ID: 33134465
[TBL] [Abstract][Full Text] [Related]
13. Fecal Immunochemical Test Versus Fecal Calprotectin for Prediction of Mucosal Healing in Crohn's Disease.
Inokuchi T; Kato J; Hiraoka S; Takashima S; Nakarai A; Takei D; Sugihara Y; Takahara M; Kawano S; Harada K; Okada H
Inflamm Bowel Dis; 2016 May; 22(5):1078-85. PubMed ID: 26891256
[TBL] [Abstract][Full Text] [Related]
14. Defining Faecal Calprotectin Thresholds as a Surrogate for Endoscopic and Histological Disease Activity in Ulcerative Colitis-a Prospective Analysis.
Walsh A; Kormilitzin A; Hinds C; Sexton V; Brain O; Keshav S; Uhlig H; Geddes J; Goodwin G; Peters M; Collins G; Travis S
J Crohns Colitis; 2019 Mar; 13(4):424-430. PubMed ID: 30445625
[TBL] [Abstract][Full Text] [Related]
15. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
D'Haens G; Ferrante M; Vermeire S; Baert F; Noman M; Moortgat L; Geens P; Iwens D; Aerden I; Van Assche G; Van Olmen G; Rutgeerts P
Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983
[TBL] [Abstract][Full Text] [Related]
16. Levels of Fecal Calprotectin Are Associated With the Severity of Postoperative Endoscopic Recurrence in Asymptomatic Patients With Crohn's Disease.
Boschetti G; Laidet M; Moussata D; Stefanescu C; Roblin X; Phelip G; Cotte E; Passot G; Francois Y; Drai J; Del Tedesco E; Bouhnik Y; Flourie B; Nancey S
Am J Gastroenterol; 2015 Jun; 110(6):865-72. PubMed ID: 25781366
[TBL] [Abstract][Full Text] [Related]
17. Endoscopic Factors Influencing Fecal Calprotectin Value in Crohn's Disease.
Goutorbe F; Goutte M; Minet-Quinard R; Boucher AL; Pereira B; Bommelaer G; Buisson A
J Crohns Colitis; 2015 Dec; 9(12):1113-9. PubMed ID: 26351383
[TBL] [Abstract][Full Text] [Related]
18. Point of care testing of fecal calprotectin as a substitute for routine laboratory analysis.
Hejl J; Theede K; Møllgren B; Madsen KV; Heidari A; Á Steig A; Fenger M
Pract Lab Med; 2018 Mar; 10():10-14. PubMed ID: 29234707
[TBL] [Abstract][Full Text] [Related]
19. Fecal calprotectin as a biomarker of microscopic bowel inflammation in patients with spondyloarthritis.
Campos JF; Resende GG; Barbosa AJA; de Carvalho SC; Lage JA; Cunha PFS; de Souza SCS; Ferrari MLA
Int J Rheum Dis; 2022 Sep; 25(9):1078-1086. PubMed ID: 35855677
[TBL] [Abstract][Full Text] [Related]
20. Factors Associated With Fecal Calprotectin Sample Collection Compliance: An IBD Center Quality Improvement Project.
Fenton D; Choi NK; Garcia NM; Dyer EC; Cohen NA; Rubin DT
Crohns Colitis 360; 2022 Oct; 4(4):otac042. PubMed ID: 36778515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
